Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep > NAM working with the World Hepatitis Alliance and the European Liver Patients Association www.nam.org.uk www.worldhepatitisalliance.org www.elpa-info.org Markus Cornberg presenting at The International Liver Congress. Image: EASL Education @EASLeduEASL 2019: Pangenotypic regimensPangenotypic hepatitis C drug combinations curing almost all people who complete treatment, real-world studies show. ELPA board member Gamal Shiha presenting the Egyptian pilot study at The International Liver Congress. Image: ELPA @HepatitisEuropeEASL 2019: Hepatitis C screening policiesSame-day hepatitis C treatment initiation can be achieved at large scale, Egyptian pilot study shows. News from EASL 2019: The International Liver CongressVisit our conference pages Margaret Hellard presenting at The International Liver Congress. Image: @AnnetteGaudino and @TAGTeam_TweetsEASL 2019: Finance and funding$51 billion price tag for eliminating hepatitis C by 2030. Hepatitis bulletinSign up for our free monthly hepatitis news bulletin. New to hepatitis?Read our introductory information on viral hepatitis > infohep news Antiviral therapy Tenofovir may lower the risk of liver cancer more than entecavir Liz Highleyman / 18 April 2019 People with hepatitis B who were treated with tenofovir disiproxil fumarate (TDF; Viread) were less likely to develop hepatocellular carcinoma (HCC) than those treated with entecavir (Baraclude) in a large observational study, according ... Antiviral therapy Core protein inhibitor shows promising activity against hepatitis B Liz Highleyman / 16 April 2019 An experimental hepatitis B virus (HBV) core protein inhibitor led to greater reductions in HBV viral load and residual HBV genetic material when added to nucleoside/nucleotide analogues, which could lead to a functional ... Monitoring response to treatment Simplified monitoring for hepatitis C is as effective as standard monitoring Keith Alcorn / 16 April 2019 People who had a simplified monitoring schedule of hepatitis C viral load tests at the beginning of treatment and 12 weeks after completing treatment were just as likely to be cured as ... Hepatitis D Bulevirtide is a potential cure for hepatitis B and D Liz Highleyman / 16 April 2019 Bulevirtide, formerly known as Myrcludex B, led to suppression of hepatitis delta virus (HDV) and a functional cure of hepatitis B virus (HBV) in some people with both viruses when combined with pegylated ... NAFLD Obeticholic acid improves liver fibrosis in people with NASH Liz Highleyman / 12 April 2019 Obeticholic acid (Ocaliva) led to a significant improvement in liver fibrosis related to non-alcoholic steatohepatitis (NASH), offering a potential future option for an increasingly common liver disease with no good current therapies, researchers ... View all infohep news Editors' picks from other sources Previous HAV vaccination does not reliably protect some patients with HIV Healio / 18 April 2019 England hits WHO 2020 hepatitis C target three years early The Pharmaceutical Journal / 18 April 2019 Hepatic Steatosis Highly Prevalent in Young Adults With Lifelong HIV Infectious Disease Advisor / 17 April 2019 Experts warn of fatty liver disease 'epidemic' in young people The Guardian / 12 April 2019 Health expert says hepatitis C could be eliminated quickly in Scotland BBC News / 12 April 2019 Global hepatitis response gains ground – More action needed to achieve universal health coverage targets World Health Organization / 12 April 2019 Second-generation thiazolidinedione, MSDC-0602K may significantly improve liver enzymes, fibrosis, and glycaemic markers with minimal adverse events, according to a Phase 2b study EASL / 12 April 2019 ‘Real-world’ studies in Germany and the USA confirm high rates of sustained virological response with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) in individuals with chronic HCV infection failing DAAs EASL / 12 April 2019 Hepatitis C could be prevented worldwide by reducing transmission in people who inject drugs University of Bristol / 12 April 2019 Summary from CROI 2019 for viral Hepatitis, from Jürgen Rockstroh NATAP / 09 April 2019 View all news from other sources Latest library resources Safer heroin injecting TypeWeb page Published2013 AuthorJon Derricott A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel [2012] TypeWeb page CountryRussian Federation, Turkey, Western and Central Europe Published2013 AuthorLiver International Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 TypeWeb page CountryUnited States PublishedApril 2013 AuthorAmerican Association for the Study of Liver Diseases View all resources Looking for country specific news, resources and services?Visit our country information pages > Keep up to date with the latest hepatitis newsSign up for our free monthly email bulletin >